SCHEMBL1055855

SCHEMBL1055855

COC(=O)c1cc2c([nH]1)CCC2Cc1cccc(C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.40
CACNA1F O60840 1/20 0.39
CACNA1D Q01668 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
ROCK1 Q13464 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
HTR6 P50406 1/20 0.37
KCNH2 Q12809 1/20 0.37
NLRP3 Q96P20 1/20 0.36
MGLL Q99685 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
EPHX1 P07099 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEP1A Q16819 1/20 0.35
MEP1B Q16820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005067 0.90 ESR1 (0.35) ROCK2CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL1006757 0.87 ROCK2 (0.40) ROCK2KCNH2MGLLCHRM2CHRM1
SCHEMBL1003014 0.85 MMP2 (0.39) ESR1ESR2
SCHEMBL1004824 0.85 ALDH1A1 (0.41)
SCHEMBL1005233 0.84 ESR1 (0.37) ESR1ESR2TRPA1
SCHEMBL1005383 0.84 MMP1 (0.41) CHRM2CHRM1CHRM3ESR1ESR2
SCHEMBL2074424 0.84 MMP1 (0.41) MRGPRX4HTR6ESR1ESR2
SCHEMBL1004611 0.84 MMP1 (0.45) ROCK2
SCHEMBL1005522 0.84 POLB (0.42) SLC6A2SLC6A3ESR1ESR2
SCHEMBL12952158 0.84 ESR1 (0.37) ROCK2HTR6ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE ROCK2 2419/4885CACNA1F 1042/4885CACNA1D 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.